Tavapadon aims to treat Parkinson’s motor symptoms by mimicking dopamine in a once-a-day oral dose. And the pivotal, ...

Parkinson's affects more than 1 million people in the US. Only 10 to 20% of people with Parkinson's experience symptoms ...

If you notice more than one of these symptoms, it's worth discussing them with your doctor. Trouble Moving or Walking ...

Simple external cues, such as lines on the floor, can help Parkinson’s patients focus their efforts and overcome the ...

Parkinson’s disease is a progressive neurological disorder in which ongoing changes in the brain affect and interfere with ...

The neurodegenerative disease impacts almost 10 million people globally, who at best can hope for therapies that slow and ...

Researchers at the Foundation have uncovered new insights into the complex link between dopamine and rest tremor in Parkinson ...

Managing patients with Parkinson's disease should be viewed as part of a hospital CMO's responsibility for patient safety and ...

“The positive results across all three Phase 3 TEMPO trials underscore the potential of tavapadon as a first-in-class D1/D5 ...

Centogene NV and ROPAD consortium publish data from a landmark study identifying genetic variants that may respond to ...

Why digital measurements startup Koneksa Health thinks it can help pharma measure if their drugs are effective in people with ...